These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34024700)

  • 1. Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy.
    Wakeham K; Murray L; Muirhead R; Hawkins MA; Sebag-Montefiore D; Brown S; Murphy L; Thomas G; Bell S; Whibley M; Morgan C; Sleigh K; Gilbert DC
    Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):638-649. PubMed ID: 34024700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
    Gilbert DC; Serup-Hansen E; Linnemann D; Høgdall E; Bailey C; Summers J; Havsteen H; Thomas GJ
    Br J Cancer; 2016 Jan; 114(2):134-7. PubMed ID: 26730577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
    Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
    Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
    Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
    Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
    Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
    Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
    Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal.
    Serup-Hansen E; Linnemann D; Skovrider-Ruminski W; Høgdall E; Geertsen PF; Havsteen H
    J Clin Oncol; 2014 Jun; 32(17):1812-7. PubMed ID: 24821878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
    de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
    Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.
    Martin D; Rödel F; Balermpas P; Rödel C; Fokas E
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
    Martin D; Rödel F; Balermpas P; Winkelmann R; Fokas E; Rödel C
    Front Oncol; 2019; 9():1200. PubMed ID: 31788452
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Steinhäuser K; Kreis NN; Friemel A; Martin D; Wieland U; Rave-Fränk M; Balermpas P; Fokas E; Louwen F; Rödel C; Yuan J
    Radiother Oncol; 2018 Feb; 126(2):214-221. PubMed ID: 29122359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
    Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
    Balermpas P; Michel Y; Wagenblast J; Seitz O; Weiss C; Rödel F; Rödel C; Fokas E
    Br J Cancer; 2014 Jan; 110(2):501-9. PubMed ID: 24129245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts.
    Ito T; Takayanagi D; Sekine S; Hashimoto T; Shimada Y; Matsuda M; Yamada M; Hamamoto R; Kato T; Shida D; Kanemitsu Y; Boku N; Kohno T; Takashima A; Shiraishi K
    Sci Rep; 2023 Mar; 13(1):3587. PubMed ID: 36869079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy.
    Balci Topuz B; Sert F; Sezak M; Soylu M; Yalman D; Ozkok S
    Oncol Lett; 2024 Aug; 28(2):395. PubMed ID: 38966586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.